Chemical Structure
Paprotrain [57046-73-8]
AG-CR1-3504
Overview
- SupplierAdipoGen Life Sciences
- Product NamePaprotrain [57046-73-8]
- Delivery Days Customer10
- CAS Number57046-73-8
- CertificationResearch Use Only
- Estimated Purity>98%
- Molecular FormulaC16H11N3
- Molecular Weight245.3
- Scientific DescriptionCell permeable and reversible kinesin-specific MKLP-2 (mitotic kinesin-like protein 2) inhibitor [1]. Inhibits the recruitment of the chromosome passenger proteins survivin and aurora B to the central spindle during anaphase chromosome segregation [1]. Moderate DYRK1A inhibitor (IC50= 5.5 microM). Lead compound [3]. - Chemical. CAS: 57046-73-8. Formula: C16H11N3. MW: 245.3. Cell permeable and reversible kinesin-specific MKLP-2 (mitotic kinesin-like protein 2) inhibitor. Inhibits the recruitment of the chromosome passenger proteins survivin and aurora B to the central spindle during anaphase chromosome segregation. Moderate DYRK1A inhibitor (IC50= 5.5 microM). Lead compound.
- SMILES[H]\C(=C(\C#N)C1=CNC2=C1C=CC=C2)C1=CN=CC=C1
- Storage Instruction-20°C,2°C to 8°C
- UNSPSC12352200
References
- Relocation of Aurora B and Survivin from Centromeres to the Central Spindle Impaired by a Kinesin-Specific MKLP-2 Inhibitor: S. Tcherniuk, et al.; Angew. Chem. (Int'l Ed.) 49, 8228 (2010)
- New MKLP-2 inhibitors in the paprotrain series: Design, synthesis and biological evaluations: C. Labrière, et al.; Bioorg. Med. Chem. 24, 721 (2016)
- Further investigation of paprotrain: Towards the conception of selective and multi-targeted CNS kinase inhibitors: C. Labrière, et al.; Eur. J. Med. Chem. 124, 920 (2016)